MRNA CANCER VACCINES AND THERAPEUTICS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-22027 | Pharmaceuticals And Medical
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
mRNA Cancer Vaccines and Therapeutics Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET
7.1 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA MRNA CANCER VACCINES AND THERAPEUTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Arcturus Therapeutics Inc
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 BioNTech SE
16.3 CureVac AG
16.4 Etherna
16.5 Ethris GmbH
16.6 GlaxoSmithKline PLC
16.7 Moderna Therapeutics Inc
16.8 Translate Bio Inc
16.9 Argos Therapeutics, Inc
16.10 Sangamo Therapeutics Inc
16.11 Pfizer
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeStandardization of Cancer Treatment mRNA Vaccine
Individualized Cancer Treatment mRNA Vaccine
Infectious Disease Treatment mRNA Vaccine
Infection Prevention mRNA Vaccine
By Application
Cancer
Infectious Disease
Gene Editing
Protein Replacement
Companies
Arcturus Therapeutics Inc
BioNTech SE
CureVac AG
Etherna
Ethris GmbH
GlaxoSmithKline PLC
Moderna Therapeutics Inc
Translate Bio Inc
Argos Therapeutics, Inc
Sangamo Therapeutics Inc
Pfizer
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.